Billboards seen around Seattle say "States That Legalized Marijuana Have 25% Fewer Opioid-Related Deaths." KING 5's Elisa Hahn consults 3 expert sources, including ADAI Senior Research Scientist Dr. Bia Carlini, about the truth of that claim. WATCH video from KING 5 News.
Find out more about marijuana's impact on health and safety at LearnAboutMarijuanaWA.org
| |
|
Marijuana legalization policies are evolving rapidly in Washington State, in the U.S., and internationally. On ADAI's LearnAboutMarijuanaWA.org website, the section on Marijuana Law and Policy has been updated with current information about:
We discuss topics such as commonalities in legalization policies adopted by states, conflicts between state and federal laws, workplace policies about marijuana use and employee testing, "middle ground" approaches to legalization, and much more. We welcome your feedback @ adai.uw.edu!
| |
|
"Does marijuana use cause anxiety, or will it help calm me down?"
"Which is safer: smoking plant marijuana or vaping a concentrate?"
"What if I want to cut down on my pot use, but I don't want to quit?"
Staff and volunteers of the Washington Recovery Help Line have a new science-based training to help them answer questions from callers about marijuana use and its consequences. "Marijuana Training for Help Line Staff: Science-based Answers to Frequently Asked Questions” is an online, interactive training developed by Dr. Bia Carlini and colleagues at the UW Alcohol & Drug Abuse Institute in consultation with Help Line staff.
The goal of the training is to increase knowledge about marijuana and Washington's marijuana laws, and to suggest resources that helpline staff may not yet have in their toolbox. Most of the resources described in the training can be found on ADAI’s Learn About Marijuana WA website.
The 1.5 hour training covers five modules:
In July 2017, the team of Meg Brunner, MLIS, Bia Carlini, PhD, MPH, and Sharon Garrett, MPH, met with Helpline director Robyn Smith, MSW (second from right), her staff and volunteers, to introduce the training. Staff were excited to learn the training had been created to address their own questions and those of Help Line callers!
Although the training was developed for the Washington Recovery Help Line and some information is specific to them, it may be of interest to others who routinely answer questions about marijuana use, including health care providers, educators, and professionals in substance use treatment or prevention.
Development of the training was funded by the Washington State Dedicated Marijuana Fund for research at the University of Washington.
Related: Carlini BH, Garrett SB. Drug helplines and adult marijuana users: an assessment in Washington, Colorado, Oregon, and Alaska. Substance Abuse 2017 (in press). This study helped the developers to understand the concerns and knowledge gaps among helpline workers that are addressed in the training.
LearnAboutMarijuanaWA.org website developed by ADAI to provide science-based information about marijuana to the public.
| |
|
Results of ADAI research are published in articles in peer-reviewed journals and presented at scientific conferences. We also produce brief reports and summaries on a variety of topics, aimed at the wider audience of providers, policy makers, and the public. These reports are supported by diverse funding sources.
Funder: WA State Div. of Behavioral Health & Recovery (DBHR):
Funder: I-502 for research on marijuana:
Funder: ADAI and other sources:
| |
|
Legalization has brought increased public attention to cannabis and its medicinal properties. Developed for health professionals, this web-based training presents current information and clinical practice guidelines on the use of medicinal cannabis for the treatment of chronic pain. CME/CPE are available for physicians, nurses, osteopaths, pharmacists, and physician assistants.
Updated in 2017 to incorporate the newest developments in research and law in this evolving field, the training provides you with up-to-date information on the use of medicinal cannabis for the treatment of chronic pain in two online modules. The first is a basic primer on the mechanism of action of medicinal cannabis, its medical uses, and Washington State law. The second focuses on the best clinical practices associated with the recommendation of medicinal cannabis. This training provides useful tools for healthcare providers in their discussion with patients about the use of medicinal cannabis in the treatment of chronic pain.
Up to 2.0 AMA PRA Category 1 Credits™ are available upon completion of the training.
For more information and to begin the training: http://adai.uw.edu/mcacp/
| |
|
The Consumers’ Perspectives on the Function of Marijuana in their Lives study is being conducted by the University of Washington. The study looks at how adults who regularly consume marijuana think about its role in their lives.
You may be eligible if you are:
More information and study survey: http://adai.uw.edu/MJ%20Perspectives%20Recruitment%20Flyer-071716.pdf
| |
|
Using funds from the I-502 Dedicated Marijuana Fund intended for marijuana research at the University of Washington, ADAI awarded eight marijuana research grants during the last two grant cycles. The goal of the Small Grant program is to stimulate research by providing initial funding for promising pilot projects which may ultimately be developed into full research studies with outside grant support.
October 2015 cycle
March 2016 Cycle
Grants for non-marijuana studies are awarded with funds from the regular Small Grants program. To read more about these projects and for information about the ADAI Small Grants Program, visit our website: http://adai.uw.edu/grants/smgrant.htm
| |
|
| |
|
On May 20, 2016, the UW Alcohol & Drug Abuse Institute hosted its 2nd research symposium on marijuana in Washington State. This 1-day event featured experts from the UW and other research and community organizations; nearly 200 people attended from research, policy, public health, treatment, and prevention communities.
Presentations and Q & A sessions explored new and persistent questions from the changing landscape of legal marijuana, including:
The Keynote was presented by Rosalie Liccardo Pacula, PhD, Director of the BING Center for Health Economics and Co-Director of the Drug Policy Research Center at RAND Corporation.
Video, slides, and related resources can be viewed on the symposium website: http://adai.uw.edu/mjsymposium/
| |
|
Earlier this week, the National Institutes of Health convened a two-day Marijuana and Cannabinoids: A Neuroscience Research Summit focused on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system, as well as policy. Both the adverse and the potential therapeutic effects of the cannabinoid system were discussed.
The goal of the summit is to ensure evidence-based information is available to inform practice and policy, particularly important at this time given the rapidly shifting landscape regarding the recreational and medicinal use of marijuana. The meeting was sponsored by NIDA, NIAAA, NCCIH, NIMH, and NINDS.
Agenda: http://apps1.seiservices.com/nih/mj/2016/Agenda.aspx
The summit was video recorded for later viewing:
| |
|
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
